Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Blood Biomarker Identification in Cervical Cancer: Performance of Cell-free DNA Versus Extracellular Vesicles

NCT07796672 is registered in ClinicalTrials.gov with Queensland Centre for Gynaecological Cancer as lead sponsor.

NCT NCT07796672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07796672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Blood Biomarker Identification in Cervical Cancer: Performance of Cell-free DNA Versus Extracellular Vesicles
Lead sponsor
Queensland Centre for Gynaecological Cancer
Phase
Observational
Overall status
Recruiting
Start date
September 15, 2026
Completion date
September 15, 2032
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical adenocarcinoma, cervical squamous cell carcinoma